Skip to main content
. 2016 Apr 15;31(6):984–991. doi: 10.1093/ndt/gfw062

FIGURE 2:

FIGURE 2:

(A) Percent of participants in the Daily Trial with SPI II score >47 by time and treatment. (B) Percent of participants in the Nocturnal Trial with SPI II score >47 by time and treatment.